Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $14.56 ($826K) on 2026-04-14, disclosed to the SEC on 2026-04-16.
Scheduled sale ($826k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.56 | 19,060 | $278K | 33.6% |
| 2 | $14.61 | 19,060 | $278K | 33.7% |
| 3 | $14.18 | 19,060 | $270K | 32.7% |
| Total | $14.45 avg | 57,180 | $826K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |